Expanded Access for Marizomib

NO_LONGER_AVAILABLE

Conditions studied: Solid Tumor

In brief

This is an expanded access program (EAP) for eligible participants designed to provide access to Marizomib.

Key facts

Study ID

NCT04644107

Run by

Celgene

Last updated by the study team

2020-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Bristol Myers Squibb — Summit, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.